If you are one of the 60,000 + women diagnosed with DCIS this year, you now have a way to gain more peace of mind about what to think and do about it.
A company called PreludeDx has scientifically validated a bio-marker test which evaluates a woman’s breast tissue sample and provides a “personalized” risk assessment based on her unique biology.
The test is called DCISionRT.
Had this test been available in 2010 when I was diagnosed with DCIS, I would have learned extremely valuable information that would have given me, my family AND my team of physicians great confidence in MY decisions.
Instead I found myself in a very lonely place. I was continually scared and pressured by physicians as well as women in online DCIS forums to succumb to aggressive cancer treatments — procedures and drugs that felt more toxic, scary and harmful than the actual DCIS diagnosis.
Fast forward 8.5 years.
The PreludeDx team discovered my story and arranged to test my original DCIS biopsy tissue from 2010.
He personally went over the results of my DCISionRT test with me which you can see below.
My Score was less than 1 out of 10 (0.8 / 10), with 9% risk of total 10-year recurrence and no expected benefit from radiation therapy.
Is this the picture of a woman in need of a mastectomy or weeks of daily radiation?
Is this someone who deserved to be told by a breast cancer physician, “Don’t be stupid Donna… at least do 3 weeks of radiation.“
Unfortunately, DCISionRT was not available in 2010.
While I am thankful I had my strong intuition and a number of articles and studies on suspected overdiagnosis and overtreatment of DCIS, I now have the scientific proof that I made the right choices and said NO to weeks of radiation or mastectomy.
Hopefully thousands of women today can be spared the frightening feeling that comes with uncertainty and can instead have more personalized information to support their decisions for active surveillance if they are low-risk rather than be continually pressured towards a one-size-fits-all highly aggressive treatment protocol.
In the past, studies have shown 97% of women end up doing aggressive treatments for DCIS. Lack of knowledge about the biological nature of DCIS coupled with fear and anxiety have been strong motivators.
Not only does DCISionRT give a woman and her family tremendous peace of mind, it can provide physicians the scientific evidence to feel more confident in supporting both someone like me — with a low-risk DCIS — to someone who is at a more elevated risk.
I believe DCISionRT will help shift the paradigm away from needless emotional trauma, (worry, overwhelm, confusion, uncertainty, intimidation and fear), as well as help stop the problem known as “over-treatment” of DCIS.
I hope all health-care providers and organizations concerned with “early detection” of breast cancer embrace this important test.
When it comes to DCIS, there is no price tag for peace of mind.
If your doctor is unaware or unsupportive of DCISionRT, please contact Jennifer Cohrs for assistance:
I recently enjoyed a lab tour and meeting with the PreludeDx team at their office in Laguna, California.
Thank you Prelude Dx for advancing the science of DCIS and for treating me like a VIP!
To learn more about DCISionRT, click here.